Found: 57
Select item for more details and to access through your institution.
Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2355707, doi. 10.1001/jamanetworkopen.2023.55707
- By:
- Publication type:
- Article
84 Using Opportunistic Sampling and Remnant Blood Samples to Develop Pediatric Pharmacokinetic Models to Inform Antidepressant Dosing.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 21, p. 7993, doi. 10.1093/hmg/dds302
- By:
- Publication type:
- Article
A comprehensive evaluation of collapsing methods using simulated and real data: excellent annotation of functionality and large sample sizes required.
- Published in:
- Frontiers in Genetics, 2014, v. 5, p. 1, doi. 10.3389/fgene.2014.00323
- By:
- Publication type:
- Article
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
- Published in:
- Nature Genetics, 2015, v. 47, n. 6, p. 607, doi. 10.1038/ng.3283
- By:
- Publication type:
- Article
Association of SLCO1B1 *14 Allele with Poor Response to Methotrexate in Juvenile Idiopathic Arthritis Patients.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 1, p. 58, doi. 10.1002/acr2.1008
- By:
- Publication type:
- Article
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00099
- By:
- Publication type:
- Article
Enhancing pharmacokinetic and pharmacodynamic knowledge in pediatrics.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 7, p. 578, doi. 10.1002/phar.2840
- By:
- Publication type:
- Article
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 7, p. 675, doi. 10.1002/phar.2767
- By:
- Publication type:
- Article
Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 9, p. 1172, doi. 10.1002/phar.1981
- By:
- Publication type:
- Article
Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 52, doi. 10.1634/theoncologist.2017-0243
- By:
- Publication type:
- Article
Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1621, doi. 10.1007/s40262-023-01294-8
- By:
- Publication type:
- Article
Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31213
- By:
- Publication type:
- Article
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Implementation of CYP2D6-guided opioid therapy at Cincinnati Children's Hospital Medical Center.
- Published in:
- American Journal of Health-System Pharmacy, 2023, v. 80, n. 13, p. 852, doi. 10.1093/ajhp/zxad025
- By:
- Publication type:
- Article
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
Corrigendum: RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci.
- Published in:
- Nature Immunology, 2009, v. 10, n. 6, p. 655, doi. 10.1038/ni.1735
- By:
- Publication type:
- Article
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 12, p. e2029411, doi. 10.1001/jamanetworkopen.2020.29411
- By:
- Publication type:
- Article
Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.833217
- By:
- Publication type:
- Article
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.749692
- By:
- Publication type:
- Article
Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 6, p. 1, doi. 10.1111/cts.13837
- By:
- Publication type:
- Article
Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2130, doi. 10.1111/cts.13600
- By:
- Publication type:
- Article
Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 1768, doi. 10.1111/cts.13571
- By:
- Publication type:
- Article
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 660, doi. 10.1111/bcp.15506
- By:
- Publication type:
- Article
Clinical implementation of pharmacogenetics and model‐informed precision dosing to improve patient care.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 4, p. 1418, doi. 10.1111/bcp.14426
- By:
- Publication type:
- Article
Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2837, doi. 10.3390/cancers13112837
- By:
- Publication type:
- Article
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216328
- By:
- Publication type:
- Article
From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 515, doi. 10.1002/cpt.3281
- By:
- Publication type:
- Article
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1065, doi. 10.1002/cpt.3162
- By:
- Publication type:
- Article
Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 860, doi. 10.1002/cpt.3184
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 51, doi. 10.1002/cpt.2903
- By:
- Publication type:
- Article
Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 69, doi. 10.1002/cpt.2890
- By:
- Publication type:
- Article
PharmVar GeneFocus: SLCO1B1.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 782, doi. 10.1002/cpt.2705
- By:
- Publication type:
- Article
CYP2D6*9 and *41: Does the Activity Value Assigned to these Alleles Need to be Reduced to more Accurately Predict Phenotype?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 6, p. 1208, doi. 10.1002/cpt.2371
- By:
- Publication type:
- Article
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1007, doi. 10.1002/cpt.2557
- By:
- Publication type:
- Article
Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 559, doi. 10.1002/cpt.2340
- By:
- Publication type:
- Article
Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 589, doi. 10.1002/cpt.2312
- By:
- Publication type:
- Article
Planning and Conducting a Pharmacogenetics Association Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 688, doi. 10.1002/cpt.2270
- By:
- Publication type:
- Article
Opportunity for Genotype‐Guided Prescribing Among Adult Patients in 11 US Health Systems.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 1, p. 179, doi. 10.1002/cpt.2161
- By:
- Publication type:
- Article
MTXPK.org: A Clinical Decision Support Tool Evaluating High‐Dose Methotrexate Pharmacokinetics to Inform Post‐Infusion Care and Use of Glucarpidase.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 635, doi. 10.1002/cpt.1957
- By:
- Publication type:
- Article
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 50, doi. 10.1002/cpt.1661
- By:
- Publication type:
- Article
Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 2, p. 298, doi. 10.1002/cpt.1494
- By:
- Publication type:
- Article
Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 1, p. 49, doi. 10.1002/cpt.1165
- By:
- Publication type:
- Article
A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 1006, doi. 10.3390/jpm12061006
- By:
- Publication type:
- Article
Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1188, doi. 10.3390/jpm11111188
- By:
- Publication type:
- Article
The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 7, p. 615, doi. 10.3390/jpm11070615
- By:
- Publication type:
- Article